People / Staff

Manuel Vázquez Carrera

Search publications

Publications

  • Jové M, Laguna JC and Vazquez M.

    Agonist-induced activation releases peroxisome proliferator-activated receptor beta/delta from its inhibition by palmitate-induced nuclear factor-kappaB in skeletal muscle cells.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1734(1): 52-61. Number of citations: 26

    [doi:10.1016/j.bbalip.2005.02.002]

  • Planavila A, Laguna JC and Vazquez M.

    Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.

    JOURNAL OF BIOLOGICAL CHEMISTRY . 280(17): 17464-17471. Number of citations: 109

    [doi:10.1074/jbc.M414220200]

  • Planavila A, Alegret M, Sánchez RM, Rodríguez-Calvo R, Laguna JC and Vazquez M.

    Increased Akt protein expression is associated with decreased ceramide content in skeletal muscle of troglitazone-treated mice.

    BIOCHEMICAL PHARMACOLOGY . 69(8): 1195-1204. Number of citations: 26

    [doi:10.1016/j.bcp.2005.01.015]

  • Viñals M, Bermúdez I, Llaverias G, Alegret M, Sanchez RM, Vazquez M and Laguna JC.

    Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages.

    CARDIOVASC RES . 66(1): 141-149. Number of citations: 40

    [doi:10.1016/j.cardiores.2004.12.024]

  • Planavila A, Rodríguez-Calvo R, Jové M, Michalik L, Wahli W, Laguna JC and Vazquez M.

    Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.

    CARDIOVASC RES . 65(4): 832-841. Number of citations: 151

    [doi:10.1016/j.cardiores.2004.11.011]

  • Planavila A, Laguna JC and Vazquez M.

    Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1687(1-3): 76-83. Number of citations: 86

    [doi:10.1016/j.bbalip.2004.11.004]

  • Llaverias G, Vazquez M, Sánchez RM, Noé V, Ciudad CJ, Laguna JC and Alegret M.

    Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism.

    JOURNAL OF LIPID RESEARCH . 45(11): 2015-2024. Number of citations: 60

    [doi:10.1194/jlr.M400049-JLR200]

  • Sanguino E, Roglans N, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs.

    BIOCHEMICAL PHARMACOLOGY . 68(7): 1411-1421. Number of citations: 16

    [doi:10.1016/j.bcp.2004.06.008]

  • Sanguino E, Bejarano R, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Sexual dimorphism in lipid metabolic phenotype associated with old age in Sprague-Dawley rats.

    EXPERIMENTAL GERONTOLOGY . 39(9): 1295-1306. Number of citations: 18

    [doi:10.1016/j.exger.2004.06.007]

  • Vazquez M and Silvestre JS.

    Insulin analogues in the management of diabetes.

    Methods And Findings In Experimental And Clinical Pharmacology . 26(6): 445-461. Number of citations: 25